Biotech

All Articles

Analysts go into Avidity's DMD succeed, disclosing nuances in data

.Avidity Biosciences impressed investors with stage 1/2 information in Duchenne muscle dystrophy (DM...

Actinogen's cortisol blocker neglects stage 2 depression research

.Actinogen Medical's cortisol blocker has actually missed the major endpoint of a stage 2 study in d...

Bivictrix chooses going personal only means to take ADC right into clinic

.Antibody-drug conjugates (ADCs) have actually gone to the center of numerous a billion-dollar biobu...

TPG leadings up funds to $580M for assets around lifestyle scientific researches

.Resource manager TPG, which has actually sustained biotechs including Sionna Therapeutics and Santa...

Merck quits phase 3 TIGIT test in bronchi cancer for impossibility

.Merck &amp Co.'s TIGIT course has actually suffered yet another obstacle. Months after shuttering a...

After a hard year, Exscientia folds right into Recursion

.After a year defined by pipe cuts, the shift of its own CEO and cutbacks, Exscientia is going to co...

Cullinan, after $25M bargain, restore bispecific to Harbour

.Cullinan Rehab was actually excited enough with Harbour BioMed's bispecific immune reactor that it ...

A better examine Strong Biotech's Ferocious 15

.In this full week's incident of "The Top Pipe," our experts are actually diving in to Fierce Biotec...

Lilly faces period 2 failure of tau-targeting med

.The confetti is actually still soaring from Eli Lilly's party celebrating the commendation of Alzhe...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of considerable leadership hirings, firings a...